Saving Minds show

Saving Minds

Summary: Dr. Elliot Goldstein and Shanti Skiffington discuss the future of medicine for Alzheimer’s and Parkinson’s diseases with the world's leading researchers.

Join Now to Subscribe to this Podcast

Podcasts:

  Introducing Intrabodies with Dr. Johanne Kaplan. | File Type: audio/mpeg | Duration: 12:00

Introducing Intrabodies with Dr. Johanne Kaplan.

 Worried about aducanumab? Don’t be. Dr. Jim Kupiec explains | File Type: audio/mpeg | Duration: 12:41

Worried about aducanumab? Don’t be. Dr. Jim Kupiec explains

 “For a COVID-19 antibody test, selectivity is key.” | File Type: audio/mpeg | Duration: 18:46

“For a COVID-19 antibody test, selectivity is key.”

 *Re-Release* Episode 4 – How do Biomarkers Work? | File Type: audio/mp4 | Duration: 13:19

*Re-Release* Episode 4 – How do Biomarkers Work?

 Episode 20 –Dr. José Luis Molinuevo of the BarcelonaBeta Brain Research Center on the Future of Alzheimer's Disease | File Type: audio/mpeg | Duration: 27:48

Shanti and Elliot talk to Dr. José Luis Molinuevo of the BarcelonaBeta Brain Research Center on the Future of Alzheimer's Disease

 Episode 19 – Dr. Stephen Salloway, Rhode Island’s Man of the Year, on a brighter future for Alzheimer’s disease | File Type: audio/mpeg | Duration: 23:04

Dr. Stephen Salloway and Dr. James Kupiec reflect on Aducanumab, the exciting progress that has been made in the AD research community over the last 20 years, and the future of AD research.  

 Episode 18 – Dr. Sharon Cohen Deconstructs the Aducanumab Data From CTAD | File Type: audio/mpeg | Duration: 32:06

This week Shanti and Elliot talk to Dr. Sharon Cohen, director of Toronto Memory Program. They discuss the recent news surrounding aducanumab, as well as Dr. Cohen's recent trip to CTAD.

 Episode 17 – The Data Behind Biogen's Recent Decision with Dr. James Kupiec | File Type: audio/mpeg | Duration: 18:26

This week Shanti and Elliot discuss the data behind Biogen's recent decision to revive their Aducanumab study.

 Episode 16 – In the news: Biogen and Neuroinflammation with Dr. Johanne Kaplan | File Type: audio/mpeg | Duration: 13:41

This week Shanti and Johanne discuss the recent news coming out of Biogen and how Neuroinflammation relates to Alzheimer's.

 Episode 15 – Protein Misfolding Diseases with Dr. Lary Walker | File Type: audio/mp4 | Duration: 17:49

This week Shanti and Elliot talk to Dr. Lary Walker, a research professor at Emory University. They discuss what Alzheimer’s, Parkinson’s and more have in common.

 Episode 14 – Finding Treatment for Alzheimer's and Other Diseases with Brain Canada's Inez Jabalpurwala | File Type: audio/mp4 | Duration: 20:01

This week Shanti and Elliot are joined by Brain Canada's CEO Inez Jabalpurwala. They discuss the wonderful work that Brain Canada has been doing, and the next steps in the search for a cure for Alzheimer's, Parkinson's and other diseases.

 Episode 13 – Understanding Multiple System Atrophy, Prions and Neuron Death | File Type: audio/mp4 | Duration: 15:58

This week Shanti and Elliot discuss Multiple System Atrophy, prions and how greater understanding of each can help other neurodegenerative diseases.

 Episode 12 – A Deeper Dive Into Biomarkers with Dr. James Kupiec Reporting on AAIC Research | File Type: audio/mp4 | Duration: 16:35

This week Shanti is joined by Dr. James Kupiec, Chief Medical Officer at ProMIS Neurosciences. Shanti and Dr. Kupiec do a deep dive on Biomarkers and discuss recent research coming out of AAIC.

 Episode 11 – What Is TDP43 and What Are We Going to Do About It? | File Type: audio/mp4 | Duration: 14:03

Elliot is back to discuss the TDP43 protein, which has been implicated in the development of a recently discovered form of dementia as well as ALS. Shanti and Elliot talk about why TDP43 is important, and the efforts to neutralize the misfolded protein in the brain before it can destroy brain cells.

  Episode 11 – What Is TDP43 and What Are We Going to Do About It? | File Type: audio/mp4 | Duration: 25:04

Elliot is back to discuss the TDP43 protein, which has recently been implicated in the development of a recently discovered form of Dementia and ALS. Shanti and Elliot talk about why TDP43 is important, and the efforts to neutralize the misfolded protein in the brain before it can destroy brain cells.

Comments

Login or signup comment.